[Experimental defibrination syndromes].
D000818:Animals; D001772:Blood Cell Count; D001778:Blood Coagulation Disorders; D001779:Blood Coagulation Factors / Q000378:metabolism; D001783:Blood Flow Velocity; D001787:Blood Group Incompatibility; D001792:Blood Platelets; D003030:Coagulase / Q000494:pharmacology; D004731:Endotoxins / Q000494:pharmacology; D005337:Fibrin / Q000378:metabolism; D006493:Heparin / Q000494:pharmacology; D012157:Mononuclear Phagocyte System; D010587:Phagocytosis; D014176:Protein Biosynthesis; D011817:Rabbits; D012771:Shock, Hemorrhagic / Q000139:chemically induced; D012790:Shwartzman Phenomenon; D012911:Snakes; D013210:Staphylococcus; D013925:Thromboplastin / Q000037:antagonists & inhibitors / Q000494:pharmacology; D013927:Thrombosis; D014357:Trypsin / Q000494:pharmacology; D014688:Venoms / Q000494:pharmacology; D014859:Warfarin / Q000494:pharmacology
D001779:Blood Coagulation Factors; D003030:Coagulase; D004731:Endotoxins; D014688:Venoms; D014859:Warfarin; D005337:Fibrin; D006493:Heparin; D013925:Thromboplastin; D014357:Trypsin
Les syndromes de défibrination expérimentaux.